Published September 30, 2023 | Version https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue9,Article22.pdf
Journal article Open

Study of Anxiety and Depression in COPD (Chronic Obstructive Pulmonary Disorder) Patients of Maharashtra

Authors/Creators

  • 1. Assistant Professor, Department of Psychiatry, MIMSR Medical College Latur-413531, Maharashtra
  • 2. Associate Professor, Department of Pulmonary Medicine, L N Medical College & Research Centre, Kolar Road Bhopal, M.P.
  • 3. Senior Resident, Department of Pathology, Dr. S.C.G.M.C Nanded - 431502

Description

Background: The mechanism of depression and anxiety in COPD is still not completely understood. The biological mechanism between COPD and mental illness has to be evaluated. Method: 95 patients aged between 40-70 years with COPD in depression and anxiety was studied. They were subjected to a detailed clinical examination, and COPD was diagnosed as per GOLD guide lines with a post-bronchodilator fEv1/FEV<70 nMRC score. Spirometric study, psychological assessment by the HAM-D method, and anxiety assessment by the MADRS method. Results: 44 (46.3%) had anxiety, and 51 (53.6%) had depression. In a comparative study of no depression, respiratory and psychiatric parameters had a highly significant p value (p<0.001). Conclusion: COPD patients with co-morbid anxiety and repression experience more acute exacerbations and need pulmonary rehabilitation. Management of anxiety and depression in COPD will reduce readmissions and mortality.

 

 

Abstract (English)

Background: The mechanism of depression and anxiety in COPD is still not completely understood. The biological mechanism between COPD and mental illness has to be evaluated. Method: 95 patients aged between 40-70 years with COPD in depression and anxiety was studied. They were subjected to a detailed clinical examination, and COPD was diagnosed as per GOLD guide lines with a post-bronchodilator fEv1/FEV<70 nMRC score. Spirometric study, psychological assessment by the HAM-D method, and anxiety assessment by the MADRS method. Results: 44 (46.3%) had anxiety, and 51 (53.6%) had depression. In a comparative study of no depression, respiratory and psychiatric parameters had a highly significant p value (p<0.001). Conclusion: COPD patients with co-morbid anxiety and repression experience more acute exacerbations and need pulmonary rehabilitation. Management of anxiety and depression in COPD will reduce readmissions and mortality.

 

 

Files

IJPCR,Vol15,Issue9,Article22.pdf

Files (611.4 kB)

Name Size Download all
md5:fd61bf8be7aa94ced17d21340c770b04
611.4 kB Preview Download

Additional details

Identifiers

URL
https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue9,Article22.pdf

Dates

Accepted
2023-08-30

Software

Repository URL
https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue9,Article22.pdf
Development Status
Active

References

  • 1. Quaderi SA, Hurst JR – The unmatched global burden of COPD Glob. Health. Epidemiol. Gen. 2018, 3rd edition, 2018–220. 2. Zareifopous N, Belbu A – prevalence contribution to disease burden and management of co-morbid depression and anxiety in chronic obstructive pulmonary disease A narrative review, J. Obstr. Pulm. Dis. 2019; 16; 406-417. 3. Van Manen JG, Bindels PJ – Risk of depression in patients with chronic obstructive pulmonary disease and its determinants Thorax. 2002; 57 (5); 412-416. 4. Yahannes AM, and Alexopolous GS – Depression and anxiety in patients with COPD, Eur. Respir. Rev. 2014; 23 (133); 345–349. 5. Global Initiative on Obstructive Lung Disease, Global Strategy of Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease, 2019 Report http://www.goldcopd.org. (last accessed on October 18, 2022). 6. Baman D, Mishra S, Mishra J – Association between depression and acute pain in adults attending a tertiary care hospital in Bhubaneswar J. Clin. Diagn. Res. 2015; 95 (7); 98–102. 7. Schnneider C, Jick SS – COPD and risk of depression in chest 2010, 137 (2); 341-347. 8. Loup Chen P Zhang P – effects of smoking depression and anxiety on mortality of COPD patients, Resp. Care 2014; 59 (1): 54–61. 9. Good win RD, Lavole KL- depression, anxiety, and COPD. The unexplained role of nicotine dependence Nicotine Tab. Res. 2012, 14 (2); 176–183. 10. Pumar MI, Gray CR – Anxiety and depression are important psychological co-morbidities of COPD. J. Thorax Dis. 2014; 6; 1615-1631. 11. Mortucci VL, Richmond B Fate or coincidence: do COPD and major depression share genetic risk factors? 30; 619-628. 12. Schuler M, Wittmann M – The interaction among aspects of dyspnea and symptoms of depression in COPD patients. J, Affect, Discord. 2018; 240; 33–40. 13. Fan VS, Ramsay SD – Sex depression and risk of hospitalisation and mortality in COPD. Arch. Intern Med. 2007; 167; 2345–2353.